Clover Health published a supplemental Q&A document to address frequently asked shareholder questions following its third quarter 2026 earnings announcement. The update discusses long-term projections through 2028, membership cohort maturation, and plans to improve the company's Adjusted SG&A ratio through operating leverage as it scales.
Clover Health announced that CMS awarded its PPO Medicare Advantage plans a 5-star rating and its HMO plan a 4.5-star rating for 2027. The 5-star rating for the PPO plans, which cover ~98% of the company's members, allows for year-round enrollment and higher quality-based payments in 2028. The rating calculation was impacted by a court decision removing 20 specific measures currently under appeal.